Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical immunology (Orlando, Fla.) Fla.), 2020-10, Vol.219, p.108550-108550, Article 108550
Hauptverfasser:	Chrousos, George P., Meduri, G.Umberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - therapeutic use Betacoronavirus - drug effects Betacoronavirus - immunology Betacoronavirus - pathogenicity Biomarkers - blood Coronavirus Infections - drug therapy Coronavirus Infections - immunology Coronavirus Infections - metabolism Coronavirus Infections - virology COVID-19 Cytokine Release Syndrome - drug therapy Cytokine Release Syndrome - immunology Cytokine Release Syndrome - metabolism Cytokine Release Syndrome - virology Cytokines - antagonists & inhibitors Cytokines - genetics Cytokines - immunology Drug Administration Schedule Gene Expression Regulation Glucocorticoids - therapeutic use Homeostasis - drug effects Homeostasis - immunology Humans Hydrocortisone - blood Immunity, Innate - drug effects Inflammation - prevention & control NF-kappa B - genetics NF-kappa B - immunology Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - immunology Pneumonia, Viral - metabolism Pneumonia, Viral - virology SARS-CoV-2 Stress, Physiological Treatment Outcome Vitamins - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!